<DOC>
	<DOC>NCT02253043</DOC>
	<brief_summary>Purpose: The purpose of this clinical study is to verify the long term effectiveness and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for patients with cognitive, behavioral, and functional disability of Alzheimer's disease.</brief_summary>
	<brief_title>The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease</brief_title>
	<detailed_description>Other: Deep Brain Stimulation Implanted device Subjects will then be instructed to apply PINS Deep Brain Stimulation Device for 12 month.</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>1. Subject is aged 40 to 80 years old; 2. Subject with AD diagnosed according to the criteria for probable AD as defined by the National Institute of Neurological Disorders and StrokeAlzheimer's Disease and Related Disorders Association (NINCDSADRDA); 3. Subject have received the diagnosis of AD within the past 2 years; 4. Subject have a CDR of 0.5 or 1.0; 5. Score between 20 and 28 on the Mini Mental State Examination 6. have been taking a stable dose of cholinesterase inhibitors for a minimum of 6 months. 1. Patients with hearing impairment; 2. Failures of important organs and in severe conditions 3. Be reluctant or disabled to receive neuropsychological assessments; 4. Participate in other clinical trial; 5. Has a life expectancy of &lt; 1 year. 6. The investigator and/or enrollment review committee, would preclude participation in the study.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Alzheimer's Disease</keyword>
</DOC>